The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Current Status on CM for Biologics: Development to Clinical
Speakers will provide insights on the current stage of deployment of CM for biological molecule clinical manufacturing from the point of view of process technologies, facility assets, and manufacturing operations. Examples of successes as well as challenges encountered will be shared.
The Biopharmaceutical Industry Emerging Continuous and Integrated Platform for Recombinant Protein Jon Coffman, PhD, Senior Director of Bioprocess Technology and Engineering AstraZeneca
Perspectives on the Development of Continuous Manufacturing for Biological Products
Mark Brower, Principal Scientist
Merck
Novel Technologies to Enable Continuous Manufacturing of Biologics
Govind Rao, PhD, Director, Center for Advanced Sensor Technology
University of Maryland, Baltimore County
Moderator(s):
Antonio
R. Moreira,
PhD,
Vice Provost, Academic Affairs,
University of Maryland
Speaker(s):
Jon
Coffman,
PhD,
Senior Director of Bioprocess Technology and Engineering,
AstraZeneca
Mark
Brower,
Principal Scientist,
Merck & Co., Inc.
Govind
Rao,
PhD,
Professor & Director, Center for Advanced Sensor Technology,
University of Maryland, Baltimore County
Credits
Credits: None available.
You must be logged in and own this session in order to
post comments.
Ushma Mehta
7/31/20 12:14 pm
Hello, Is Jon Coffman going to share his presentation on "The Biopharmaceutical Industry Emerging Continuous and Integrated Platform for Recombinant Protein" ?
Thank you
Ushma Mehta
7/31/20 12:14 pm
Hello, Is Jon Coffman going to share his presentation on "The Biopharmaceutical Industry Emerging Continuous and Integrated Platform for Recombinant Protein" ? Thank you